Other News To Note
Tuesday, January 10, 2012
Apricus Biosciences Inc., of San Diego, entered a licensing agreement granting Abbott, of Abbott Park, Ill., the exclusive rights to market Vitaros (alprostadil), Apricus Bio's treatment for erectile dysfunction, in Canada. Abbott will commercialize and market Vitaros in Canada where the drug was approved by Health Canada in late 2010, with launch anticipated in 2012.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.